CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 85 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $255 | -74.5% | 6,715 | +22.8% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 5,469 | +0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 5,468 | +5.5% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 5,181 | +58.5% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 3,268 | +25.1% | 0.00% | – |
| Q3 2021 | $3,000 | -50.0% | 2,612 | -31.5% | 0.00% | – |
| Q2 2021 | $6,000 | -14.3% | 3,811 | +0.0% | 0.00% | – |
| Q1 2021 | $7,000 | +133.3% | 3,810 | +30.9% | 0.00% | – |
| Q4 2020 | $3,000 | -88.0% | 2,910 | -54.1% | 0.00% | – |
| Q3 2020 | $25,000 | -65.8% | 6,334 | -28.8% | 0.00% | – |
| Q2 2020 | $73,000 | +143.3% | 8,890 | +52.9% | 0.00% | – |
| Q1 2020 | $30,000 | – | 5,815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $3,107,000 | 1.71% |
| ETF MANAGERS GROUP, LLC | 14,138,998 | $8,534,000 | 0.17% |
| Ikarian Capital, LLC | 948,526 | $584,000 | 0.09% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 318,668 | $196,000 | 0.03% |
| Platform Technology Partners | 45,000 | $28,000 | 0.01% |
| XTX Topco Ltd | 34,476 | $21,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 947,083 | $583,000 | 0.01% |
| Penserra Capital Management LLC | 537,236 | $330,000 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,070,006 | $2,506,000 | 0.01% |
| Tekla Capital Management LLC | 154,310 | $95,000 | 0.00% |